A practical and effective strategy in East Asia to prevent anti‐D alloimmunization in patients by C/c phenotyping of serologic RhD‐negative blood donors. Issue 4 (16th September 2021)

• Record Type: Journal Article
• Authors: Ito, Shoichi; Ohto, Hitoshi; Ogiyama, Yoshiko; Irino, Michiyo; Omokawa, Susumu; Shibasaki, Itaru; Ogasawara, Kenichi; Uchikawa, Makoto; Nollet, Kenneth E.; Flegel, Willy A.
• Is Part Of: EJHaem. Volume 2:Issue 4(2021)
• Page Start: 750
• Page End: 756
• Publication Date: 2021-09-16
• Subjects: alloimmunization -- anti‐D -- DEL -- red cell transfusion -- RhD‐negative; Hematology -- Periodicals; 616.15
• DOI: 10.1002/jha2.292
• Languages: English
• ISSNs: 2688-6146

Abstract

Abstract: Serologic RhD‐negative red cells can cause anti‐D alloimmunization if they carry the Asian‐type DEL or other DEL variants. RHD genotyping is a viable countermeasure if available, but inexpensive alternatives are worthy of consideration. RhD‐negative blood donors in Japan were studied by anti‐D adsorption‐elution and RHD genotyping. We collated published case reports of RhD‐negative red cell transfusions associated with inexplicable anti‐D immunization. Of 2754 serologic RhD‐negative donors, 378 were genotyped D/d . Anti‐D adsorption‐elution revealed 63.5% (240 of 378) to be DEL, of whom 96.7% (232 of 240) had the 1227G > A variant, diagnostic for the Asian‐type DEL. All 240 donors also carried at least one C antigen; none had a cc phenotype. The chance of transfusing DEL red cells to genuinely RhD‐negative Asian patients (based on a three‐unit transfusion) ranges from 16.7% in Korea to 69.4% in Taiwan, versus 0.6% in Germany. Among 22 RhD‐negative recipients of serologic RhD‐negative red cells, who produced new or increased anti‐D antibody titers, all 17 from East Asia were transfused with red cells with a C‐positive phenotype or known to be Asian‐type DEL or both. Serologic RhD‐negative East Asians with a cc phenotype can be red cell donors for RhD‐negative recipients, especially those of childbearing potential.